May 15, 2018 β Results of the AVIATOR 2 international registry data show a discrepancy between physician perception and ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
May 14, 2018 β New clinical evidance showsΒ common therapy options for psoriasis (PSO), a chronic inflammatory skin ...
Β
In many cases, the diagnosis and management of patients with rare diseases can require the participation of ...
May 7, 2018 β The U.S. Food and Drug Administration (FDA) has approved Portola Pharmaceuticals' Andexxa, the first ...
April 30, 2018 β Point of Care Decision Support (PCDS) announced the release of a new version 2.0 of their ...
April 6, 2018 β Pfizer Inc. announced that the Tafamidis Phase 3 Transthyretin Cardiomyopathy (ATTR-ACT) study met its ...
There were several notable presentations of new data on cardiovascular technologies at the recent 2018 American College ...
March 23, 2018 β Patients with foot ulcers or gangrene who received the experimental drug JVS-100 did not show evidence ...
March 22, 2018 β The experimental drug andexanet was associated with control of serious bleeding in patients taking a ...
March 20, 2018 β Four weeks of treatment with a novel inhaled medication failed to improve exercise capacity, daily ...
March 20, 2018 β During the 12 months after undergoing noncardiac surgery, patients with or at risk for heart disease ...
March 20, 2018 β Febuxostat, a gout drug that has been in use for nearly a decade, was found to significantly increase ...
March 20, 2018 β The anti-inflammatory drug canakinumab had no effect on rates of newly diagnosed diabetes in people who ...
March 20, 2018 β Treatment with the blood-thinning drug dabigatran significantly reduced the risk of death, heart attack ...
March 20, 2018 β Getting a large dose of a statin did not have an impact on major adverse cardiac events among a broad ...